Firma Clinical Research, a boutique contract research organization (CRO), will exhibit at this year’s Drug Information Association (DIA) Global Annual Meeting on June 23-27 in San Diego, California.
Firma team members will be at Booth #1949 to discuss the company’s unique approach to patient-centric clinical trials. From protocol design and recruitment through data analysis and submission, Firma redefines what it means to put patients at the center of a study.
“Everyone today is talking about patient centricity, but few are actually putting it into practice. At Firma, our integrated suite of specialized solutions is designed to both make participation in the clinical trials process easier and more valuable for patients, and produce higher-quality data for sites and sponsors. The Firma team is looking forward to discussing what being ‘patient centric’ really means in a clinical trial with DIA attendees,” said Michael Woods, CEO, Firma Clinical Research.
As the largest, longest-running event in the life sciences industry, DIA 2019 Global Annual Meeting is designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. The event will host thousands of professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe and 400+ exhibiting companies.
About Firma Clinical Research
Firma is a boutique contract research organization (CRO) that believes a patient-centric approach is the key to unlocking positive outcomes in the drug and medical device development process. Using an integrated suite of specialized solutions, Firma makes the clinical trials process easier and more valuable for patients, and produces higher-quality data for sites and sponsors.